DADC
NARI

D.A. Davidson & Co’s Inari Medical, Inc. Common Stock NARI Stock Holding History

D.A. Davidson & Co’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,491
Closed -$638K – 1513
2024
Q4 		$638K Buy
12,491
+892
+8% +$43.8K 0.01% 936
2024
Q3 		$478K Buy
11,599
+143
+1% +$6.87K ﹤0.01% 1024
2024
Q2 		$552K Buy
11,456
+695
+6% +$30.8K ﹤0.01% 937
2024
Q1 		$516K Buy
10,761
+191
+2% +$10.2K ﹤0.01% 977
2023
Q4 		$686K Buy
10,570
+188
+2% +$11.3K 0.01% 833
2023
Q3 		$679K Buy
10,382
+3,296
+47% +$207K 0.01% 803
2023
Q2 		$412K Buy
7,086
+49
+0.7% +$3.09K ﹤0.01% 977
2023
Q1 		$434K Sell
7,037
-417
-6% -$25K ﹤0.01% 929
2022
Q4 		$474K Sell
7,454
-60
-0.8% -$4.35K 0.01% 864
2022
Q3 		$546K Buy
7,514
+417
+6% +$31K 0.01% 785
2022
Q2 		$483K Buy
7,097
+160
+2% +$11.5K 0.01% 838
2022
Q1 		$629K Buy
6,937
+24
+0.3% +$1.96K 0.01% 796
2021
Q4 		$631K Buy
6,913
+392
+6% +$33.6K 0.01% 802
2021
Q3 		$529K Buy
6,521
+546
+9% +$45.9K 0.01% 823
2021
Q2 		$557K Buy
5,975
+295
+5% +$28.6K 0.01% 804
2021
Q1 		$608K Buy
5,680
+3,265
+135% +$339K 0.01% 743
2020
Q4 		$211K Buy
+2,415
New +$171K ﹤0.01% 955

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

D.A. Davidson & Co's NARI Position: Q1 2025 in Review

D.A. Davidson & Co sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 12,491 shares — an estimated $638K sold.

D.A. Davidson & Co first reported a position in NARI in Q4 2020 and held it in 17 quarters. The position peaked at $686K in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • D.A. Davidson & Co reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • D.A. Davidson & Co sold 12,491 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $638K.
  • D.A. Davidson & Co first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 17 quarters.
  • D.A. Davidson & Co's Inari Medical, Inc. Common Stock position peaked at $686K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on D.A. Davidson & Co's 13F filing for Q1 2025, filed 28 Apr 2025.